Treatment of drug-induced psychosis in Parkinson's disease with clozapine
Greene, P.; Cote, L.; Fahn, S.
Advances in Neurology 60: 703-706
1993
ISSN/ISBN: 0091-3952 PMID: 8420214 Document Number: 407394
Document emailed within 1 workday
Related Documents
Wolk, S.I.; Douglas, C.J. 1992: Clozapine treatment of psychosis in Parkinson's disease: a report of five consecutive cases Journal of Clinical Psychiatry 53(10): 373-376Friedman, A. 1985: Drug-induced dyskinesia during the treatment of Parkinson disease--biochemical studies Neurologia i Neurochirurgia Polska 19(5): 401-403
Krüger, R.; Weiss, D. 2011: Evidence-based therapeutic algorithms in the treatment of depression, dementia and psychosis in Parkinson's disease MMW Fortschritte der Medizin 153(14): 29-32; Quiz 33
Bayerlein, K.; Frieling, H.; Beyer, B.; Kornhuber, J.; Bleich, S. 2004: Drug-induced psychosis after long-term treatment with levetiracetam Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 49(12): 868
Bajulaiye, R.; Addonizio 1992: Clozapine in the treatment of psychosis in an 82-year-old woman with tardive dyskinesia Journal of Clinical Psychopharmacology 12(5): 364-365
Factor, S.A.; Molho, E.S.; Podskalny, G.D.; Brown, D. 1995: Parkinson's disease: drug-induced psychiatric states Advances in Neurology 65: 115-138
Pfeiffer, C.; Wagner, M.L. 1994: Clozapine therapy for Parkinson's disease and other movement disorders American Journal of Hospital Pharmacy 51(24): 3047-3053
Godwin-Austen, R.B. 1999: Psychosis and hallucinations in Parkinson's disease Advances in Neurology 80: 401-402
Marttila, R. 2004: Which drug to use for the initiation of treatment for early Parkinson's disease Duodecim; Laaketieteellinen Aikakauskirja 120(5): 587-590
Borison, R.L.; Diamond, B.I.; Sinha, D.; Gupta, R.P.; Ajiboye, P.A. 1988: Clozapine withdrawal rebound psychosis Psychopharmacology Bulletin 24(2): 260-263
Llau, M.E.; Nguyen, L.; Senard, J.M.; Rascol, O.; Montastruc, J.L. 1994: Drug-induced Parkinson syndrome: 10 years of drug vigilance Therapie 49(5): 459-460
Alfaro, J.; Berdichevsky, E.; Conte, G.; Tellez, C. 1994: A case of neutropenia and agranulocytosis induced by clozapine. The importance of a drug surveillance program for their early detection Revista Medica de Chile 122(6): 694-698
Soler Roibal, M.A.; Oca Bravo, L.; Montejo Iglesias, L.M. 1999: The clozapine-induced hypersalivation and its treatment Actas Espanolas de Psiquiatria 27(6): 408-411
Gram, L.F. 1976: Drug information. Bone marrow depression in treatment with clozapine (Leponex) Ugeskrift for Laeger 138(21): 1271-1273
DeRemer, C.E.; Andrick, B.J.; Capito, M.D. 2019: Clozapine drug-induced pancreatitis of intermediate latency of onset confirmed by de-challenge and re-challenge International Journal of Clinical Pharmacology and Therapeutics 57(1): 37-40
Soloshenko, E.N. 1986: Treatment of patients with drug-induced disease Vestnik Dermatologii i Venerologii 3: 54-56
Miller, W.C.; McCurdy, L. 1970: Lithium carbonate: a new drug in the treatment of manic-depressive psychosis Journal of the South Carolina Medical Association 66(9): 315-317
Spivak, B.; Mester, R.; Abesgaus, J.; Wittenberg, N.; Adlersberg, S.; Gonen, N.; Weizman, A. 1997: Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients Journal of Clinical Psychiatry 58(7): 318-322
Chen, X.; Gumina, G.; Virga, K.G. 2019: Recent Advances in Drug Repurposing for Parkinson's Disease Current Medicinal Chemistry 26(28): 5340-5362
Gehlen, W. 1980: Adverse effects of drug therapy in Parkinson disease Medizinische Monatsschrift für Pharmazeuten 3(4): 104-110